University of Wisconsin-Madison researchers are developing a universal vaccine that would protect against multiple diseases and coronavirus strains, including COVID-19. Last fall, the National Institute of Allergy and Infectious Diseases invested $7 million in the UW-Madison research collaboration, named the Pan-Coronavirus Vaccine consortium. Yoshihiro Kawaoka, a pathobiological sciences professor in the School of Veterinary Medicine, is leading the team working toward a universal vaccine.
Office of Strategic Communication